AR115992A2 - ANTIGEN BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR - Google Patents
ANTIGEN BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTORInfo
- Publication number
- AR115992A2 AR115992A2 ARP190102375A ARP190102375A AR115992A2 AR 115992 A2 AR115992 A2 AR 115992A2 AR P190102375 A ARP190102375 A AR P190102375A AR P190102375 A ARP190102375 A AR P190102375A AR 115992 A2 AR115992 A2 AR 115992A2
- Authority
- AR
- Argentina
- Prior art keywords
- antibodies
- antigen
- lepr
- binding fragments
- leptin
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente proporciona anticuerpos y fragmentos de unión a antígeno de anticuerpos que se unen al receptor de leptina (LEPR), y métodos de uso de los mismos. De acuerdo con determinadas formas de realización, la presente incluye anticuerpos y fragmentos de unión a antígeno de anticuerpos que se unen a LEPR y activan la señalización de LEPR. En otras formas de realización, la presente incluye anticuerpos y fragmentos de unión a antígeno de anticuerpos que se unen a LEPR y mejoran la sensibilización de LEPR a un antígeno. En determinadas formas de realización, la presente incluye anticuerpos y fragmentos de unión a antígeno de anticuerpos que se unen a LEPR en presencia y en ausencia de leptina. En determinadas formas de realización, la presente incluye anticuerpos y fragmentos de unión a antígeno de anticuerpos que inducen la señalización en células que expresan mutantes de LEPR que, en otro caso, exhiben señalización defectuosa o dificultosa en presencia de leptina. Los anticuerpos y fragmentos de unión a antígeno de la presente son útiles para el tratamiento de lipodistrofias y otras enfermedades y trastornos asociados a la deficiencia de leptina o a la resistencia a la leptina o provocados por estas.The present provides antibodies and antigen-binding fragments of antibodies that bind to the leptin receptor (LEPR), and methods of using the same. In accordance with certain embodiments, the present includes antibodies and antigen-binding fragments of antibodies that bind to LEPR and activate LEPR signaling. In other embodiments, the present includes antibodies and antigen-binding fragments of antibodies that bind to LEPR and enhance the sensitization of LEPR to an antigen. In certain embodiments, the present includes antibodies and antigen-binding fragments of antibodies that bind to LEPR in the presence and in the absence of leptin. In certain embodiments, the present includes antibodies and antigen-binding fragments of antibodies that induce signaling in cells expressing LEPR mutants that otherwise exhibit defective or impaired signaling in the presence of leptin. The antibodies and antigen-binding fragments herein are useful for the treatment of lipodystrophies and other diseases and disorders associated with or caused by leptin deficiency or resistance to leptin.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562240021P | 2015-10-12 | 2015-10-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR115992A2 true AR115992A2 (en) | 2021-03-17 |
Family
ID=61158540
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP160103105A AR106319A1 (en) | 2015-10-12 | 2016-10-11 | ANTIGEN UNION PROTEINS THAT ACTIVATE THE LEPTINE RECEIVER |
ARP190102375A AR115992A2 (en) | 2015-10-12 | 2019-08-21 | ANTIGEN BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP160103105A AR106319A1 (en) | 2015-10-12 | 2016-10-11 | ANTIGEN UNION PROTEINS THAT ACTIVATE THE LEPTINE RECEIVER |
Country Status (2)
Country | Link |
---|---|
AR (2) | AR106319A1 (en) |
MA (1) | MA42186B1 (en) |
-
2016
- 2016-10-11 AR ARP160103105A patent/AR106319A1/en unknown
- 2016-10-11 MA MA42186A patent/MA42186B1/en unknown
-
2019
- 2019-08-21 AR ARP190102375A patent/AR115992A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
MA42186B1 (en) | 2019-08-30 |
MA42186A1 (en) | 2018-07-31 |
AR106319A1 (en) | 2018-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2018003852A2 (en) | Antigen binding proteins that activate the leptin receptor | |
DOP2020000128A (en) | ANTI-TREM2 ANTIBODIES AND RELATED METHODS | |
CO2019012210A2 (en) | Anti-trem2 antibodies and methods of using them | |
ECSP18095014A (en) | BISPECIFIC BINDING PROTEINS THAT BIND AN IMMUNOMODULATING PROTEIN AND A TUMOR ANTIGEN | |
CO2018011364A2 (en) | Anti-il-33 antibodies, compositions, methods and uses thereof | |
CL2018003136A1 (en) | Specific binding proteins and uses thereof. | |
CL2017000278A1 (en) | Bispecific t-cell activating antigen binding molecules | |
UY37698A (en) | PROTEINS OF UNION TO TREM2 ANTIGENS AND USES OF THESE | |
CU20170169A7 (en) | FACTOR ANTIBODIES XI | |
CR20170351A (en) | ICOS UNION PROTEINS | |
CO7250445A2 (en) | St2 antigen binding proteins | |
EA201890285A1 (en) | ANTIBODIES AGAINST PD-1, ACTIVATED ANTIBODIES AGAINST PD-1 AND METHODS OF THEIR APPLICATION | |
BR112018010891A2 (en) | antibodies and antibody fragments for site specific conjugation | |
CU20160101A7 (en) | IMMUNOGLOBULINA WITH FAB IN TANDEM | |
AR111288A1 (en) | ANTI-PHF-TAU ANTIBODIES AND ITS USES | |
ECSP18096095A (en) | ALPHA-SINUCLEIN ANTIBODIES AND USES OF THEM | |
CO2018011195A2 (en) | Compositions comprising a coformulation of anti-pd-l1 and anti-ctla-4 antibodies | |
BR112017003194B8 (en) | ANTIBODY OR ANTIGEN-BINDING FRAGMENT OF THE SAME THAT SPECIFICALLY BINDS TO HUMAN LAG3, COMPOSITION, AND, USE OF THE ANTIBODY OR AN ANTIGEN-BINDING FRAGMENT OF THESE AND THE COMPOSITION | |
BR112018015480A2 (en) | pd-l1-binding antigen binding proteins | |
BR112016011401A2 (en) | aplnr modulators and uses thereof | |
BR112019005139A2 (en) | anti-il-33 antibodies and uses thereof | |
BR112015030356A2 (en) | methods of treatment of a taupathy | |
CO2018012497A2 (en) | Interferon beta antibodies and uses thereof | |
CL2019000019A1 (en) | Antibodies with low immunogenicity and use thereof | |
CO2019009035A2 (en) | Glucagon Receptor Binding Proteins and Methods for Using Them |